Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 4Pain, Postoperative 2Neoplasms 2Agnosia 2Recurrence 1Postoperative Cognitive Complications 1Non-Muscle Invasive Bladder Neoplasms 1Neoplastic Cells, Circulating 1Myofibroma 1Melanoma 1Liver Neoplasms 1Leiomyoma 1Inflammatory Bowel Diseases 1Diverticulitis 1Delirium 1Colonic Neoplasms 1Cancer Surgery 1

Interventions

Cyclophosphamide 151Dexamethasone 140Rituximab 83fludarabine 78Cytarabine 69Lenalidomide 68Bortezomib 63fludarabine phosphate 62Gemcitabine 62venetoclax 54Etoposide 53pembrolizumab 52pomalidomide 48Paclitaxel 48Cisplatin 47Carboplatin 47Peripheral Blood Stem Cell Transplantation 46Filgrastim 40Radiotherapy 39Calcium Dobesilate 36Busulfan 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 29Vincristine 28Temozolomide 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Recurrence × Anesthesia, Spinal × Clear all
NCT06982690 2025-05-21

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

National Taiwan University Hospital

Phase NA Not yet recruiting
370 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡